Publications :

HBV and HBsAg strongly reshape the phenotype, function, and metabolism of DCs according to patients' clinical stage

Dumolard L, Gerster T, Chuffart F, Decaens T, Hilleret MN, Larrat S, Saas P, Jouvin-Marche…

Hepatol Commun. 2025 Jan 29;9(2):e0625. doi: 10.1097/HC9.0000000000000625. PMID: 39878655; PMCID: PMC11781764.

Hypothermic Oxygenated Machine Perfusion and Static Cold Storage Drive Distinct Immunomodulation During Liver Transplantation: A Pilot Study

Aspord C, Macek Jílková Z, Bonadona A, Gerster T, Lesurtel M, Girard E, Saas P,…

Transplantation. 2025 Apr 1;109(4):658-670. doi: 10.1097/TP.0000000000005274. Epub 2024 Dec 11. PMID: 40131763.

Identification of immunogenic HLA-A*02:01 epitopes associated with HCC for immunotherapy development

Maino A, Bourov A-Flin E, Decaens T, Khochbin S, Macek Jilkova Z, Rousseaux S, Plumas…

Hepatol Commun. 2025 2025 Feb 26;9(3):e0659. doi: 10.1097/HC9.0000000000000659. PMID: 40008881; PMCID: PMC11868434

MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma

Niveau C, Cettour-Cave M, Mouret S, Sosa Cuevas E, Pezet M, Roubinet B, Gil H,…

Nat Commun. 2025 Jan 27;16(1):1083. doi: 10.1038/s41467-025-56392-x. PMID: 39870647; PMCID: PMC11772620.

Nanostructured lipid carriers based mRNA vaccine leads to a T cell-inflamed tumour microenvironment favourable for improving PD-1/PD-L1 blocking therapy and long-term immunity in a cold tumour model

Fournier C, Mercey-Ressejac M, Derangère V, Al Kadi A, Rageot D, Charrat C, Leroy A,…

EBioMedicine. 2025 Feb;112:105543. doi: 10.1016/j.ebiom.2024.105543. Epub 2025 Jan 9. PMID: 39793480; PMCID: PMC11774803.

Liver cancer in ovo models for preclinical testing

Garcia P, Wang Y, Viallet J, Mehdi NEH, Montaut E, Decaens T, Emadali A, Macek…

FASEB J 2024 Sep 15;38(17):e70029. doi: 10.1096/fj.202401416R. PMID: 39215630.

Maternal imprinting and determinants of neonates' immune function in the SEPAGES mother-child cohort

Manches O, Um K, Boudier A, Maddouri Y, Lyon-Caen S, Bayat S, Slama R, Philippat…

Front Immunol. 2023 Apr 4;14:1136749. doi: 10.3389/fimmu.2023.1136749. PMID: 37081891; PMCID: PMC10111372.

Immune responses following tocilizumab therapy to desensitize HLA-sensitized kidney transplant candidates

Jouve T, Laheurte C, Noble J, Weinhard J, Daligault M, Renaudin A, Naciri Bennani H,…

Am J Transplant 2022 Jan;22(1):71-84. doi: 10.1111/ajt.16709. Epub 2021 Jun 23. PMID: 34080291.

An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial

Charles J, Chaperot L, Hannani D, Bruder Costa J, Templier I, Trabelsi S, Gil H,…

Oncoimmunology 2020 Apr 12;9(1):1738812. doi: 10.1080/2162402X.2020.1738812. PMID: 32313721; PMCID: PMC7153838

Immunologic Features of Patients With Advanced Hepatocellular Carcinoma Before and During Sorafenib or Anti-programmed Death-1/Programmed Death-L1 Treatment

Macek Jilkova Z, Aspord C, Kurma K, Granon A, Sengel C, Sturm N, Marche PN,…

Clin Transl Gastroenterol 2019 Jul;10(7):e00058. doi: 10.14309/ctg.0000000000000058. PMID: 31295151; PMCID: PMC6708670.